Search for: "US v. Mark Stephens" Results 1101 - 1120 of 1,174
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its… [read post]
1 Aug 2008, 6:12 am
  For most of us, there are constraints on any violent impulse we might have. [read post]
19 Jul 2008, 12:19 pm
ON APPEAL FROM THE CIRCUIT COURT OF THE FIFTH JUDICIAL CIRCUIT FOR LAKE COUNTY, STATE OF FLORIDA INITIAL BRIEF OF APPELLANT Mark S. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge… [read post]
10 Jul 2008, 9:30 pm
  “As I read the Supreme Court opinion [in Boumediene v. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US… [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at… [read post]
6 Jun 2008, 6:49 am
– Removal of diplomatic immunity and alleged smear campaign: (IPKat)    Global - Trade Marks / Domain Names / Brands Working Group for the Legal Development of the Madrid System proposes replacement of ‘tacit acceptance’ regime: (Class 46), Global branding for a family-owned cult wine: can it be done? [read post]
4 Jun 2008, 3:28 am
In each, actual traffic stops using the SFSTs were investigated. [read post]
16 May 2008, 8:03 am
, (IPRoo), WIPO Director General candidates’ presentations to members: (Intellectual Property Watch), IP rights arise in UN debate on the right to participate in cultural life: (Intellectual Property Watch), IP academies agree to galvanise efforts to promote IP education: (WIPO), What business people do to maximise protection of IP: (Ezine @rticles), Lorin Brennan’s memo on interaction between UNICITRAL guide and IP rights: (IP finance), Kent’s… [read post]
19 Apr 2008, 8:50 am
(Laura Empson of Cass Business School gave a particularly nice presentation on this at lunchtime Thursday, positing that useful ways of thinking about partnership might be as analogous to The Three Musketeers, to Henry V's famous "band of brothers" speech before the Battle of Agincourt, to a buccaneer pirate ship, or, at last, to "Gone With the Wind. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]